NIPT Billing from the Practice Side

Ordering vs billing: who owns what

NIPT splits cleanly into two jurisdictions.

The trap in this arrangement: when the lab’s claim denies, the balance and the anger both land on the patient, and the patient calls the practice. Every prevention step below exists to keep that call from happening.

The prior-auth workflow

Prior authorization is the single biggest NIPT denial driver (CO-197). Build it into ordering, not billing:

1. At the visit where NIPT is offered, verify the plan’s molecular-testing auth requirement alongside eligibility.
2. Confirm which code the lab bills. An auth issued for 81420 can mismatch if the lab reports 81507.
3. Submit the auth request with the indication and gestational age; capture the auth number on the order.
4. Draw only after the auth is on file, unless the patient has accepted potential cost in writing.

Practices that run this as a standing front-desk protocol see NIPT denials drop to near zero. Practices that treat auth as the lab’s problem see the CO-197s.

The cost conversation and ABNs

Coverage is broad but not universal, so the pre-draw conversation matters:

• For Medicare-adjacent and Medicaid patients where coverage is doubtful, issue an ABN or the plan’s equivalent notice so the balance can shift to the patient properly.
• For commercial patients, document that cost was discussed. Most national labs cap self-pay NIPT at a modest flat rate; telling patients that number up front defuses the four-figure billed-charge statement that arrives when a claim denies.
• Note in the chart that the patient chose to proceed knowing coverage was unconfirmed. That sentence ends most billing disputes.

The two denial patterns

CO-50, not medically necessary, on average-risk pregnancies. The payer’s policy still keys coverage to high-risk indications and the claim carried a routine supervision-of-pregnancy code. First check whether a legitimate high-risk indication existed and was simply not coded: 35 or older at delivery, abnormal serum screen, prior aneuploidy. If the patient is truly average risk, appeal on the ACOG/SMFM guidance recommending cfDNA screening be offered to all pregnant patients; most current policies have caught up, and the stragglers reverse on documented appeal more often than not.

CO-197, no prior authorization. Purely procedural, purely preventable. If it already happened, request retro authorization inside the payer’s window (often 14 to 30 days from the date of service) with the order and indication attached. Past the window, the lab’s self-pay cap is usually the patient’s best outcome.

FAQ

Does the OB practice ever bill 81420 itself? Only if the practice owns the lab performing the sequencing, which is rare. Otherwise the practice bills the draw at most.

Can the practice bill for NIPT counseling? Pre-test counseling folded into a routine prenatal visit is part of that visit. A distinct, separately documented counseling encounter for an abnormal result can support its own E/M.

What diagnosis code should go on an average-risk order? The supervision-of-pregnancy code that matches the trimester, plus any true risk factors that exist. Never add a high-risk code the record does not support to force coverage; that is a false claim, not a workaround.

Whose job is the appeal when the lab’s claim denies? The lab files it, but it wins or loses on the practice’s documentation: the indication, the gestational age, and the counseling note. Send records promptly when the lab asks.